Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1980-03-20
1982-11-02
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2602444, A61K 31475, C07D51904
Patent
active
043573347
ABSTRACT:
VLB 3-(2-chloroethyl)carboxamide, the corresponding 4-desacetyl derivative and salts thereof, useful in treatment of neoplasms in pharmaceutical dosage forms.
REFERENCES:
patent: Re30561 (1981-03-01), Miller et al.
patent: 4096148 (1978-06-01), Miller et al.
patent: 4160767 (1979-07-01), Miller et al.
patent: 4203898 (1980-05-01), Cullinan et al.
Conrad, et al., J. Med. Chem., vol. 22, No. 4, pp. 391-400 (1979).
Barnett, et al., J. Med. Chem., 21, (1), pp. 88-96 (1978).
Gutowski Gerald E.
Miller Jean C.
Daus Donald G.
Eli Lilly and Company
Rivers Diana G.
Rowe James L.
LandOfFree
Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-623974